MDxHealth has achieved a number of significant milestones in the 1H/2017. The company continues to gain traction for its products amongst key US healthcare providers. It has expanded its product offering through the launches of AssureMDx for bladder and the IVD version of SelectMDx for prostate cancer; an agreement is already in place with a major laboratory service provider to supply the IVD test in Germany. After a positive first four month trading statement in May, we are optimistic that firs ....
22 Aug 2017
Key milestones reached in H1
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Key milestones reached in H1
MDxHealth S.A. (0O8G:LON) | 0 0 0.3% | Mkt Cap: 168.5m
- Published:
22 Aug 2017 -
Author:
Chris Redhead -
Pages:
6
MDxHealth has achieved a number of significant milestones in the 1H/2017. The company continues to gain traction for its products amongst key US healthcare providers. It has expanded its product offering through the launches of AssureMDx for bladder and the IVD version of SelectMDx for prostate cancer; an agreement is already in place with a major laboratory service provider to supply the IVD test in Germany. After a positive first four month trading statement in May, we are optimistic that firs ....